Zobrazeno 1 - 10
of 142
pro vyhledávání: '"M C Gagnieu"'
Autor:
S Bally, J Cottin, M C Gagnieu, J C Lega, C Verstuyft, S Rheims, G Lesca, M Cucherat, Guillaume Grenet
Publikováno v:
PLoS ONE, Vol 17, Iss 12, p e0278839 (2022)
Publication bias may lead to a misestimation in the association between pharmacogenetic biomarkers (PGx) and antiseizure drug's adverse effects (AEs). We aimed to assess its prevalence in this field. We searched for systematic reviews assessing PGx o
Externí odkaz:
https://doaj.org/article/f7e12b2723c74a1bb220ae372768511a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
T. Walter, M.-C. Gagnieu, J.-C. Lega, G. Grenet, J. Guitton, D. Barthelemy, L. Payen-Gay, K. Hodroj
Publikováno v:
ESMO Open
Fluoropyrimidine-based chemotherapies are widely used to treat gastrointestinal tract, head and neck, and breast carcinomas. Severe toxicities mostly impact rapidly dividing cell lines and can occur due to the partial or complete deficiency in dihydr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94f8d40a8a0d489b3fd4c1057ab3d0bd
https://doi.org/10.1016/j.esmoop.2021.100125
https://doi.org/10.1016/j.esmoop.2021.100125
Autor:
C. Triffault-Fillit, T. Ferry, F. Laurent, P. Pradat, C. Dupieux, A. Conrad, A. Becker, S. Lustig, M.H. Fessy, C. Chidiac, F. Valour, T. Perpoint, A. Boibieux, F. Biron, P. Miailhes, F. Ader, S. Roux, F. Daoud, J. Lippman, E. Braun, Y. Gillet, L. Hees, E. Servien, Y. Herry, R. Gaillard, A. Schneider, M.-H. Fessy, A. Viste, P. Chaudier, R. Desmarchelier, T. Mouton, C. Courtin, L. Louboutin, S. Martres, F. Trouillet, C. Barrey, F. Signorelli, E. Jouanneau, T. Jacquesson, A. Mojallal, F. Boucher, H. Shipkov, J. Château, F. Aubrun, I. Bobineau, C. Macabéo, F. Vandenesch, J.-P. Rasigade, F. Craighero, L. Boussel, J.-B. Pialat, I. Morelec, M. Janier, F. Giammarile, M. Tod, M.-C. Gagnieu, S. Goutelle, S. Gerbier-Colomban, T. Benet, E. Mabrut
Publikováno v:
Clinical Microbiology and Infection
Clinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2018, ⟨10.1016/j.cmi.2018.04.035⟩
Clinical Microbiology and Infection, 2019, ⟨10.1016/j.cmi.2018.04.035⟩
Clinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2018, ⟨10.1016/j.cmi.2018.04.035⟩
Clinical Microbiology and Infection, 2019, ⟨10.1016/j.cmi.2018.04.035⟩
International audience; OBJECTIVES: The high microbiologic diversity encountered in prosthetic joint infection (PJI) makes the choice of empirical antimicrobial therapies challenging, especially in cases of implant retention or one-stage exchange. De
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfc5b93c959c0e59d83fc60636a267af
https://pubmed.ncbi.nlm.nih.gov/31473327
https://pubmed.ncbi.nlm.nih.gov/31473327
Autor:
Pierre-Jean Souquet, C. Prost, L. Gérinière, L. Parmeland, D. Gomez-Abreo, V. Avrillon, A. Boibieux, Sébastien Couraud, M.-C. Gagnieu, G. Carret
Publikováno v:
Revue des Maladies Respiratoires. 29:435-439
Resume L’infection pulmonaire a Mycobacterium malmoense est rare et survient generalement sur un poumon dystrophique de meme que les infections aspergillaires. Nous rapportons le cas d’une patiente ayant developpe une aspergillose pulmonaire chro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cba3b9b71cdba7dd8a8b0fbbbf21ed03
https://doi.org/10.1016/j.rmr.2011.12.014
https://doi.org/10.1016/j.rmr.2011.12.014
Publikováno v:
Clinical Pharmacology & Therapeutics. 90:582-587
We propose a framework to enable quantitative prediction of the impact of CYP2D6 polymorphisms on drug exposure. It relies mostly on in vivo data and uses two characteristic parameters: one for the drug and the other for the genotype. The metric of i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::664d62624934b1a67dc24f9a86bb1cd5
https://doi.org/10.1038/clpt.2011.147
https://doi.org/10.1038/clpt.2011.147
Autor:
L. Becquemont, Franck Broly, Pierre Marquet, Nicolas Picard, S. Loric, Marie-Anne Loriot, B. Namour, C.-M. Dhaneens, M.-C. Gagnieu, X. Fonrose, Jean-Christophe Boyer, Alain Morel, S. Bezieau, G. Paintaud, E. Jacqz-Aigrain, C. Verstuyft, K. Peoc’h, H. Watier, M. Boisdron-Celle, Delphine Allorge, Erick Gamelin, C. Gozé, G. Bessard, P.-H. Beaune
Publikováno v:
Annales Pharmaceutiques Françaises. 65:371-381
Resume Des unites de pharmacogenetique moleculaire se sont mises en place au sein de laboratoires hospitaliers francais. L’impact clinique de ces nouvelles structures est encore limite et de nombreuses questions d’ordre organisationnel, ethique,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6e87c120457deee0317e636366374ee
https://doi.org/10.1016/s0003-4509(07)74196-2
https://doi.org/10.1016/s0003-4509(07)74196-2
Autor:
H. Rousset, J. B. Gaultier, M. C. Gagnieu, C. Guy, Jacques Ninet, K. Le Roux, A. Hot, E. Bavuz, M. Ollagnier, J. Le Scanff
Publikováno v:
Drug Safety. 30:919-990
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::35070bbf7a0e7cd0db9a69e73d77c49b
https://doi.org/10.2165/00002018-200730100-00130
https://doi.org/10.2165/00002018-200730100-00130
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Médecine et Maladies Infectieuses. 47:S144
Introduction La frequence d’arret de traitement pour effets indesirables (EI) neuropsychiatriques sous dolutegravir (DTG) est de 5,6 % dans les 12 mois [1] . La survenue de ces EI semble plus elevee chez les femmes. Nous decrivons l’observation d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8307682daeb97f8173527d56ef731918
https://doi.org/10.1016/j.medmal.2017.03.348
https://doi.org/10.1016/j.medmal.2017.03.348